VX

Vertex Pharmaceuticals Incorporated (VX1)

XETR

Currency in EUR
472.05
+3.55 (+0.76%)

Real-time Data

07:00 AM

Day's Range

464.60
472.75

52 wk Range

320.75
474.95

Analyst Ratings - VX1 - Vertex Pharmaceuticals Incorporated

Analyst ratings

DateFirmActionRating
Aug 05, 2026Truist SecuritiesMaintainsBuy
Aug 05, 2026BarclaysMaintainsOverweight
Aug 04, 2026TD CowenMaintainsBuy
Aug 04, 2026Cantor FitzgeraldMaintainsOverweight
Aug 04, 2026Canaccord GenuityMaintainsHold
Jul 13, 2026UBSMaintainsBuy
Jul 13, 2026Truist SecuritiesMaintainsBuy
Jul 07, 2026RBC CapitalMaintainsOutperform
Jul 07, 2026BairdMaintainsUnderperform
May 06, 2026BarclaysMaintainsOverweight
Items per row:

Estimates - VX1 - Vertex Pharmaceuticals Incorporated

Estimate momentum

Current quarter · How the consensus estimate has moved over the last 90 days.

Revised last month0/0

EPS estimates

PeriodAnalystsLowAverageHighYear ago
Current quarter-----
Next quarter-----
Current year-----
Next year-----

Earnings History - VX1 - Vertex Pharmaceuticals Incorporated

Estimate surprises

DateTimeEPS EstimateEPS ActualDifferenceSurprise PRC
2026-05-15--0.53-0.61-0.08‪+15.09%‬
2026-01-13-1.361.52+0.16‪+11.76%‬
2025-10-27-0.540.540.00‪0.00%‬

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.